OverviewSuggest Edit

Charles River Laboratories is a full-service, early-stage contract research organization (CRO). It operates through 3 segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment offers research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services, as well as controlled, consistent, customized primary cells and blood components derived from normal and mobilized peripheral blood, bone marrow, and cord blood. The DSA segment provides regulated and non-regulated DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. The Manufacturing segment performs specialized testing of biologics, supplies fertile chicken eggs and chickens, and delivers in vitro methods for conventional and rapid quality control testing of sterile and non-sterile biopharmaceutical and consumer products.
TypePublic
Founded1947
HQWilmington, MA, US
Websitecriver.com
Employee Ratings3.5
Overall CultureA+

Latest Updates

Employees (est.) (Dec 2020)18,400(+8%)
Job Openings1,151
Revenue (FY, 2020)$2.9 B(+12%)
Share Price (Jun 2021)$352.1
Cybersecurity ratingBMore

Key People/Management at Charles River Laboratories

James C. Foster

James C. Foster

Chairman, President & Chief Executive Officer
Antti Nurmi

Antti Nurmi

Managing Director, Discovery Services
Melanie Drayton

Melanie Drayton

Senior Director, Regulatory Affairs
William D. Barbo

William D. Barbo

Corporate Executive Vice President & Chief Commercial Officer
Jackie MacRitchie

Jackie MacRitchie

Senior Managing Director, Discovery
Stephanie Cochran

Stephanie Cochran

Associate Director of Regulatory Affairs
Show more

Charles River Laboratories Office Locations

Charles River Laboratories has offices in Wilmington, Ashland, Charleston, Chicago and in 87 other locations
Wilmington, MA, US (HQ)
251 Ballardvale St
Ashland, OH, US
1407 George Rd
Charleston, SC, US
1023 Wappoo Rd #43B
Chicago, IL, US
Iit Tower, 10 W 35th St 8th Floor
Durham, NC, US
4025 Stirrup Creek Dr #150
Frederick, MD, US
8501 Progress Drive
Show all (91)

Charles River Laboratories Financials and Metrics

Charles River Laboratories Revenue

Embed Graph
View revenue for all periods
Charles River Laboratories's revenue was reported to be $2.92 b in FY, 2020 which is a 11.5% increase from the previous period.
USD

Revenue (Q1, 2021)

824.6m

Net income (Q1, 2021)

63.9m

EBIT (Q1, 2021)

123.7m

Market capitalization (11-Jun-2021)

17.7b

Closing stock price (11-Jun-2021)

352.1

Cash (27-Mar-2021)

465.4m

EV

19.6b
Charles River Laboratories's current market capitalization is $17.7 b.
Annual
USDFY, 2018FY, 2019FY, 2020

Revenue

2.3b2.6b2.9b

Revenue growth, %

22%16%12%

Cost of goods sold

1.4b1.7b1.9b

Gross profit

840.1m958.3m1.1b
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

494.0m585.3m585.3m604.6m657.6m668.0m707.1m682.6m743.3m824.6m

Cost of goods sold

312.5m369.3m369.1m392.8m419.5m421.8m455.0m450.3m454.0m

Gross profit

181.5m216.0m216.2m211.8m238.1m246.1m252.1m232.2m289.3m

Gross profit Margin, %

37%37%37%35%36%37%36%34%39%
Annual
USDFY, 2018FY, 2019FY, 2020

Cash

195.4m238.0m228.4m

Accounts Receivable

472.2m514.0m617.7m

Prepaid Expenses

53.4m52.6m96.7m

Inventories

127.9m160.7m185.7m
Annual
USDFY, 2018FY, 2019FY, 2020

Net Income

228.7m254.1m365.3m

Depreciation and Amortization

161.8m198.1m234.9m

Inventories

(13.3m)(21.4m)(18.4m)

Accounts Payable

(12.7m)29.8m748.0k
Quarterly
USDQ1, 2018

Debt/Equity

1 x

Debt/Assets

0.4 x

Financial Leverage

2.6 x
Show all financial metrics

Charles River Laboratories Operating Metrics

FY, 2017FY, 2018FY, 2019FY, 2020

Backlog (RMS)

$96.8 m$106.5 m$128.7 m$167.6 m

Countries

23202020

Facilities

808090100

Strains

150150150150
Show all operating metrics

Charles River Laboratories Acquisitions / Subsidiaries

Company NameDateDeal Size
Retrogenix LimitedMarch 31, 2021$83 m
Cognate BioServicesMarch 29, 2021$875 m
HemaCareDecember 16, 2019
CiToxLABFebruary 13, 2019$448 m
MPI ResearchFebruary 13, 2018$800 m
KWS BioTestJanuary 11, 2018
Brains On-LineAugust 07, 2017$21 m
Agilux LaboratoriesSeptember 28, 2016$64 m
Blue Stream LaboratoriesJune 27, 2016
WIL ResearchApril 04, 2016$585 m
Show more

Charles River Laboratories Revenue Breakdown

Embed Graph

Charles River Laboratories revenue breakdown by business segment: 19.5% from RMS, 62.8% from DSA and 17.6% from Manufacturing

Charles River Laboratories revenue breakdown by geographic segment: 10.5% from Canada, 5.3% from Asia Pacific, 55.6% from US, 28.4% from Europe and 0.2% from Other

Charles River Laboratories Cybersecurity Score

Cybersecurity ratingPremium dataset

B

88/100

SecurityScorecard logo

Charles River Laboratories Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Charles River Laboratories Online and Social Media Presence

Embed Graph

Charles River Laboratories Company Culture

  • Overall Culture

    A+

    84/100

  • CEO Rating

    A+

    83/100

  • Compensation

    A+

    97/100

Learn more on Comparably

Charles River Laboratories News and Updates

Charles River Laboratories Announces Long-Term Solar Contract for North American Operations

Charles River Laboratories International, Inc. (NYSE: CRL) today announced a long-term solar energy contract to address the entirety of the Company’s North American electric power requirements with clean, renewable energy by 2023.

Charles River Laboratories to Participate in June Investor Conferences

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will virtually present at three upcoming investor conferences, including:

Charles River Laboratories to Host Virtual Investor Day

Charles River Laboratories International, Inc. (NYSE: CRL) announced that it will host a virtual Meeting with Management on Thursday, May 27th, beginning at 8:30 a.m. ET.

Charles River: Q1 Earnings Insights

Shares of Charles River (NYSE:CRL) decreased 0.1% in pre-market trading after the company reported Q1 results.

Charles River Laboratories Schedules First-Quarter 2021 Earnings Release and Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2021 financial results on Tuesday, May 4th, before the market opens. A conference call has been scheduled to discuss this information on Tuesday, May 4th, at 9:00 a.m. ET.
Show more

Charles River Laboratories Blogs

Digital Pathology

Digital Pathology arossi Fri, 04/10/2020 - 13:23 Digital Primary and Peer Review Comprehensive digital pathology has arrived at Charles River to accelerate discovery and safety programs around the globe. The average toxicology program involves the assess…

Tracking SARS-COV2 from Europe (Abstract Science, April 5 – 11)

Also: researching spike proteins and the antibiotic properties of silver The post Tracking SARS-COV2 from Europe (Abstract Science, April 5 – 11) appeared first on eureka.

Let‘s Keep on Track for Our Best Future

Given my family history of diabetes, stress-eating is not an option, even during a pandemic The post Let‘s Keep on Track for Our Best Future appeared first on eureka.

Shipping Logistics: Design and Management

Shipping Logistics: Design and Management arossi Wed, 04/08/2020 - 16:09 Global Distribution, Logistics and Cold Chain Management You’re ready to initiate testing on your new compound(s) or study material of interest, but how are you going to get your ma…

Tissue Image Analysis in Regulatory Environment

Are image analysis algorithms for digital pathology compliant with regulatory requirements? The post Tissue Image Analysis in Regulatory Environment appeared first on eureka.

Supporting COVID-19 Vaccine Developers with Rapid Sterility Release Testing

Supporting COVID-19 Vaccine Developers with Rapid Sterility Release Testing cnucci Wed, 04/08/2020 - 13:20 Rapid Vaccine Production Requires Rapid Sterility Testing To answer this need, Charles River Microbial Solutions has developed a complete rapid mic…
Show more

Charles River Laboratories Frequently Asked Questions

  • When was Charles River Laboratories founded?

    Charles River Laboratories was founded in 1947.

  • Who are Charles River Laboratories key executives?

    Charles River Laboratories's key executives are James C. Foster, Antti Nurmi and Melanie Drayton.

  • How many employees does Charles River Laboratories have?

    Charles River Laboratories has 18,400 employees.

  • What is Charles River Laboratories revenue?

    Latest Charles River Laboratories annual revenue is $2.9 b.

  • What is Charles River Laboratories revenue per employee?

    Latest Charles River Laboratories revenue per employee is $158.9 k.

  • Who are Charles River Laboratories competitors?

    Competitors of Charles River Laboratories include SNBL, Eurofins and ICON.

  • Where is Charles River Laboratories headquarters?

    Charles River Laboratories headquarters is located at 251 Ballardvale St, Wilmington.

  • Where are Charles River Laboratories offices?

    Charles River Laboratories has offices in Wilmington, Ashland, Charleston, Chicago and in 87 other locations.

  • How many offices does Charles River Laboratories have?

    Charles River Laboratories has 91 offices.